U.S. market Closed. Opens in 2 days 10 hours 8 minutes

PBAXU | Phoenix Biotech Acquisition Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-31
Revenue254.83KN/A
Cost of RevenueN/AN/A
Gross Profit254.83KN/A
Operating Expenses2.91M332.03K
Selling, General & Admin2.84M251.71K
Research & DevelopmentN/AN/A
Other Operating Expenses64.05K-80.32K
Operating Income-68.58K-332.03K
Other Expenses / Income2.84M-385.00
Before Tax Income-68.58K-332.42K
Income Tax Expenses599.16K-16.87K
Net Income-667.74K-315.55K
Interest ExpensesN/AN/A
Basic Shares Outstanding17.90M22.98M
Diluted Shares Outstanding17.90M22.98M
EBITDA-5.74M-332.03K
EBITDA Margin-2,253.38%0.00%
EBIT-68.58K-332.42K
EBIT Margin-26.91%0.00%
Financial Year End2022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙